Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Care Publish Ahead of Print published online ahead of print April 24, 2007
DOI: 10.2337/dc07-0142

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dc07-0142v1
30/8/2046    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bechtold, S.
Right arrow Articles by Schwarz, H. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bechtold, S.
Right arrow Articles by Schwarz, H. P.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

Bone SIZE normalizes with age in children and adolescents with Type 1 diabetes mellitus

Susanne Bechtold, MD, Stefanie Putzker, MD, Walter Bonfig, MD, Oliver Fuchs, MD, Isa Dirlenbach, MD and Hans Peter Schwarz, MD, PhD

University Children's Hospital, Division of Pediatric Endocrinology, Munich, Germany

Susanne.Bechtold{at}med.uni-muenchen.de

ABSTRACT

Objective:To establish whether type 1 diabetes mellitus (T1DM) has a long-term effect on bone development in children and adolescents.

Methods:Bone characteristics and muscle cross-sectional area (CSA) were analyzed cross-sectionally at study start in 41 (19f/22m) patients and reevaluated after 5.56 ± 0.4 years using peripheral quantitative computed tomography (pQCT). We hypothesize that bone size and muscle mass normalize with age.

Results:At first evaluation mean age was 9.87±2.3 years and mean disease duration 4.31± 2.9 years. Height was -0.36 ± 1.9 SD and body mass index (BMI) was 0.39 ± 0.9 SD. Parameters of bone size were low in the whole patient group (corrected for patient's height). At reevaluation, mean age was 15.44 ± 2.3 years and patients had a mean height of -0.12 ± 0.8 SD. BMI-SD had increased to 0.57 ± 1.1. Total and cortical CSA had normalized. Those patients with an increase in total CSA had a significant younger age at disease manifestation and a younger age at initial pQCT measurement. Bone size was well adapted to muscle mass expressed as the ratio of bone mineral content (BMC) per muscle mass and a close correlation was shown between rise in bone size and in muscle CSA (r=0.46, p=0.03).

Conclusion:Patients with manifestation of T1DM at an early age had transient impaired bone development. Within the follow-up period, the greatest increase in bone size was found in these patients. In adolescence, all patients had a normal bone size and an appropriate adaptation of bone on muscle.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.